- Lobbying
- merck
Lobbying Arrangements Results for 'Merck'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Communicate with congressional offices on the importance of Medicare Coverage of the shingles vaccine |
Merck
|
THOMPSON SMITCH CONSULTING GROUP | |||
Details Australian government policy on intellectual property and its impact on the Australian healthcare system |
Merck Sharp & Dohme
|
CapitalHill Advisory | |||
Details HR 5712 - Medicaid Drug Rebate Accountability Act - bill in its entirety (oppose) |
Merck & Co.
|
THE CACTUS GROUP, LLC | |||
Details Access to immunization services for adults. |
Merck & Co., Inc
|
NVG, LLC | |||
Details Fiscal Year 2021 Labor, Health and Human Services, Education and Related Agencies Appropriations Bills Antibiotics/stewardship, Ebola countermeasures, Covid-19 countermeasures |
Merck & Co., Inc.
|
SL STRATEGIES, LLC | |||
Details Farm Bill Implementation US Mexico Canada Agreement |
Intervet Inc., d/b/a Merck Animal Health
|
The Policy Group, Inc. | |||
Details H.R. 942 - The American Research and Competitiveness Act of 2011 |
Merck & Co., Inc.
|
MR. MARK RAABE | |||
Details America's Health Future Act HR 3200 America's Affordable Health Choices Act of 2009; HR 3200, HR 3590 |
Merck & Co., Inc.
|
Polsinelli Shughart PC | |||
Details Preservation of Antibiotics for Medical Treatment Act, HR 1549/S 619; animal health issues. |
Merck & Co. Inc
|
THE ADVOCACY GROUP | |||
Details Regulatory issues relating to the Medicare program. |
Merck & Co., Inc.
Pharmaceutical Manufacturer |
Sidley Austin LLP | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). |
Tiber Creek Group (on behalf of Merck & Co., Inc)
|
Tiber Creek Health Strategies, Inc. | |||
Details Issues related to international tax Corporate tax issues |
Merck & Co., Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Monitor issues as they relate to animal health . Issues concerning the Animal Drug User Fee Act. |
Williams and Jensen, PLLC on behalf of Merck & Co., INC
|
Conaway Graves Group, LLC | |||
Details Importation of prescription drugs and legislative proposals related to the Part D Medicare drug benefit. |
Merck & Co., Inc
Pharmaceutical Manufacturer |
CAPITOL HILL STRATEGIES, LLC | |||
Details Implementation of H.R.5376 - Inflation Reduction Act of 2022. Education around the Vaccine Injury Compensation Program. H.R.5378 - Lower Costs, More Transparency Act. |
Merck & Co., Inc.
|
W Strategies, LLC | |||
Details General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regu... |
Merck & Co., Inc.
|
East End Group, LLC. | |||
Details Issues related to Medicare Modernization Act of 2003 (P.L. 108-173) and general health and regulatory work and advice. |
Merck and Company, Inc.
Pharmaceutical Company. |
Alston & Bird, LLP | |||
Details Legislation to create a national electronic database to track sales of products containing pseudophedrine. |
Merck & Co., Inc.
|
Ferguson Strategies LLC | |||
Details Issues related to chemical manufacturing. |
Merck KGaA Darmstadt Germany
|
Forbes-Tate | |||
Details Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specifi... |
MERCK & CO., INC.
|
CANFIELD & ASSOCIATES, INC. | |||
Details Issues related to the pharmaceutical industry Issues related to Medicare Part B and Part D |
EMD Serono, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Stockpiling of diagnostic ingredients |
EMD Millipore
|
COVINGTON & BURLING LLP | |||
Details The Build Back Better Act. |
EMD Serono, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. Education regarding market based solutions to bring down the cost of drug prices. ... |
Merck & Co., Inc.
|
Advanced Policy Consulting, LLC | |||
Details Support increased funding for the CDC National Immunization Program (Sec 317 program). Support increased funding for the CDC National Immunization Program (Sec 317 program) |
Merck & Company
|
Cornerstone Government Affairs, Inc. | |||
Details Supporting increased funding for the CDC National Immunization Program (Sec. 317 Program) |
317 Coalition
Pharmaceutical Coalition |
Cornerstone Government Affairs, Inc. | |||
Details Issues related to transportation plans for specialty electronic chemical products. |
Versum Materials US, LLC
|
Forbes-Tate | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Merck specifically |
Merck & Co., Inc.
|
BGR Government Affairs | |||
Details Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. Education regarding market based solutions to bring down the cost of drug prices. ... |
Merck & Co., Inc.
|
Advanced Policy Consulting, LLC | |||
Details Issues related to health products and technology for animals and aquaculture. |
Merck Animal Health
|
Forbes-Tate | |||
Details Monitor issues dealing with infertility. The Family Act. Infertility tax credits. Adoption. |
EMD Serono, Inc.
|
FTI Government Affairs | |||
Details Government relations assistance in the merger of Merck & Co., Inc., and Schering-Plough |
Merck & Co., Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the taxation of the biopharmaceutical industry including international taxation |
The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma
lobbying firm |
DOMER CONSULTING, LLC | |||
Details Issues related to Part D Medicare and issues related to the drug industry. Issues related to Part D Medicare and issues related to the drug industry; issues related to vaccines; issues related to P... |
Merck
|
CAUTHEN FORBES & WILLIAMS | |||
Details Intellectual property provisions in Colombia's National Development Program |
Latin America Health Care Alliance
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Merck & Co., Inc.
Client manufacturers and develops pharmaceuticals, vaccines and biologic therapies. |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details HR 1851, The Family Act. HR 1851, The Family Act; Grandfathering of Multiple Sclerosis treatments. HR 1851, The Family Act; Grandfathering of Multiple Sclerosis treatments. |
EMD Serono
|
Tauzin Strategic Networks | |||
Details Issues related to Part D Medicare and issues related to the drug industry. Issues related to Part D Medicare and issues related to the drug industry; issues related to vaccines; issues related to P... |
Cauthen Forbes & Williams on behalf of Merck
|
Forbes-Tate | |||
Details Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare, Medicaid and generally, including proposed reform proposals. Provisions in COVID-19 recovery... |
MERCK & CO., INC
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B... |
Merck & Co., Inc
|
Tiber Creek Group | |||
Details Issues related to prescription drug pricing, vaccines, animal health, and maternal health; Issues related to Section 340B of the Public Health Service Act. Issues related to prescription drug prici... |
Merck
|
Forbes-Tate | |||
Details Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Senio... |
The Biosimilars Forum
|
Thorn Run Partners | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515 Medica... |
MERCK
|
FOLEY HOAG LLP | |||
Details General issues related to the semiconductor and life-science material manufacturing. General issues related to tax. General issues related to outbound investments. |
EMD Serono, Inc.
|
FEROX STRATEGIES | |||
Details Antibiotics/stewardship; S.1355/H.R.2940, PASTEUR Act of 2023; Value of prescription drugs; Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All ... |
Merck & Co. Inc.
|
Avenue Solutions | |||
Details 340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Drug Pricing. H.R. 830 HELP Copays Act. |
Merck & Co., Inc.
|
Todd Strategy Group | |||
Details Congressional oversight relating to drug safety and healthcare. |
MERCK & CO.
|
Ryan MacKinnon Vasapoli and Berzok LLP FKA Ryan Phillips Utrecht and MacKinnon | |||
Details H.R. 1851/S. 881, Family Act of 2013. S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality an... |
EMD Serono, Inc.
|
DLA Piper LLP (US) | |||
Details issues related to corporate and international tax reform including, IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174 and 965. Issues related to Puerto Rico incentives and excise ta... |
WTPPG on Behalf of Alliance for Biopharmaceutical Competitiveness & Innovation
|
JAHANIAN STRATEGIES LLC | |||
Details Issues related to drug pricing and the Medicare Part D program. Issues related to antimicrobials; issues related to the reauthorization of PAHPA, including S. 2852 / H.R. 6378, Pandemic All Hazards... |
Merck & Co. Inc.
|
THE NICKLES GROUP, LLC |